DOI: 10.1055/s-00000142

Frauenheilkunde up2date

Referenz

Weber-Schoendorfer C, Oppermann M, Wacker E, Bernard N, Beghin D, Cuppers-Maarschalkerweerd B, Richardson J et al. on behalf of the network of French pharmacovigilance centers.
Increased risk of birth defects after TNF-α inhibitor therapy during pregnancy? A prospective multicenter cohort study.

Birth Defects Research A 2014;
100: 523

Bibliographische Angaben herunterladen